Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| CLINICAL PHARMACY | - | Fall Semester | 3+0 | 3 | 4 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Assist.Prof. Büşra Nur ÇATTIK |
| Name of Lecturer(s) | Assist.Prof. Çağlar MACİT, Assist.Prof. Rashıda Muhammad UMAR, Assist.Prof. Neda TANER |
| Assistant(s) | |
| Aim | Describe the concepts of clinical pharmacy and patient-oriented pharmacy, and show the roles of the clinical pharmacist at rational drug use and successful pharmacotherapy in acute and chronic cases. |
| Course Content | This course contains; Introduction to Clinical Pharmacy, Patient Oriented Pharmacy, Current Status in World,Therapeutic drug monitoring and laboratory tests evaluation ,Asthma and COPD Management,Upper and Lower Respiratory System Infections,Peptic Ulcer and GERD,Diarrhea and Constipation ,NSAID, Pain and fever management ,Diabetes,Hypertension,Kidney disease ,Hyperlipidemia ,Coronary artery disease,Heart failure ,Venous thromboembolism. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Recognize the terms of clinical pharmacy and patient oriented pharmacy. | 16, 9 | A |
| 1.1. describe the clinical pharmacy and other patient oriented pharmacy terms. | 16, 9 | A |
| 1.2. Explain the general and specific roles of clinical pharmacist. | 16, 9 | A |
| 1.3. Interpret the relationships between clinical pharmacy, pharmaceutical care and good pharmacy practice. | 13, 9 | A |
| 1.4. Recognize ''the nine star pharmacist'' concept. | 19, 9 | E |
| 2. Disscusses the pharmacist's roles in the management of frequently encountered acute and chronic diseases | 13, 16, 4, 9 | |
| 2.1. Interpret the role of pharmacist in management of chronic and acute diseases. | 13, 16, 9 | A |
| 1.5. Explain the principles of rational drug use. | 16, 9 | A |
| 2.2. Follow-up on the recent pharmacotherapy updates | 10, 13, 9 | A |
| 2.3. Recognizes the sources of information about drug preference and councelling in special patient population such as geriatrics, pediatrics, pregnant and lactating patients | 10, 13, 38, 6, 9 | A |
| 3. Expalines patient-centered optimal treatment choices | 13, 16, 6, 9 | A |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 38: Care Plan, 4: Inquiry-Based Learning, 6: Experiential Learning, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam, E: Homework |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to Clinical Pharmacy, Patient Oriented Pharmacy, Current Status in World | 1, 2, 3, 4 |
| 2 | Therapeutic drug monitoring and laboratory tests evaluation | 1, 2, 3, 4 |
| 3 | Asthma and COPD Management | 1, 2, 3, 4, 5 |
| 4 | Upper and Lower Respiratory System Infections | 1, 2, 3, 4 |
| 5 | Peptic Ulcer and GERD | 1, 2, 3, 4 |
| 6 | Diarrhea and Constipation | 1, 2, 3, 4 |
| 7 | NSAID, Pain and fever management | 1, 2, 3, 4 |
| 8 | Diabetes | 1, 2, 3, 4, 5 |
| 9 | Hypertension | 1, 2, 3, 4, 5 |
| 10 | Kidney disease | 1, 2, 3, 4, 5 |
| 11 | Hyperlipidemia | 1, 2, 3, 4, 5 |
| 12 | Coronary artery disease | 1, 2, 3, 4, 5 |
| 13 | Heart failure | 1, 2, 3, 4, 5 |
| 14 | Venous thromboembolism | 1, 2, 3, 4, 5 |
| Resources |
| 1. Lecture Notes Reference Books: 2. Dipiro JT (2020), Pharmacotherapy A Pathophysiologic Approach (11th ed.) McGraw Hill, US. 3. Wiffen P (2012) Oxford Handbook of Clinical Pharmacy (2nd ed) Oxford Uni P 4. Whittleseas C (2019), Clinical Pharmacy and Therapeutics (6th ed) Elsevier |
| 5. Updated treatment guidelines |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | ||||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | ||||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | ||||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | ||||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 14 | 3 | 42 | |||
| Guided Problem Solving | 0 | 0 | 0 | |||
| Resolution of Homework Problems and Submission as a Report | 14 | 1 | 14 | |||
| Term Project | 14 | 1 | 14 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 7 | 2 | 14 | |||
| General Exam | 14 | 2 | 28 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 112 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(112/30) | 4 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| CLINICAL PHARMACY | - | Fall Semester | 3+0 | 3 | 4 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Assist.Prof. Büşra Nur ÇATTIK |
| Name of Lecturer(s) | Assist.Prof. Çağlar MACİT, Assist.Prof. Rashıda Muhammad UMAR, Assist.Prof. Neda TANER |
| Assistant(s) | |
| Aim | Describe the concepts of clinical pharmacy and patient-oriented pharmacy, and show the roles of the clinical pharmacist at rational drug use and successful pharmacotherapy in acute and chronic cases. |
| Course Content | This course contains; Introduction to Clinical Pharmacy, Patient Oriented Pharmacy, Current Status in World,Therapeutic drug monitoring and laboratory tests evaluation ,Asthma and COPD Management,Upper and Lower Respiratory System Infections,Peptic Ulcer and GERD,Diarrhea and Constipation ,NSAID, Pain and fever management ,Diabetes,Hypertension,Kidney disease ,Hyperlipidemia ,Coronary artery disease,Heart failure ,Venous thromboembolism. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Recognize the terms of clinical pharmacy and patient oriented pharmacy. | 16, 9 | A |
| 1.1. describe the clinical pharmacy and other patient oriented pharmacy terms. | 16, 9 | A |
| 1.2. Explain the general and specific roles of clinical pharmacist. | 16, 9 | A |
| 1.3. Interpret the relationships between clinical pharmacy, pharmaceutical care and good pharmacy practice. | 13, 9 | A |
| 1.4. Recognize ''the nine star pharmacist'' concept. | 19, 9 | E |
| 2. Disscusses the pharmacist's roles in the management of frequently encountered acute and chronic diseases | 13, 16, 4, 9 | |
| 2.1. Interpret the role of pharmacist in management of chronic and acute diseases. | 13, 16, 9 | A |
| 1.5. Explain the principles of rational drug use. | 16, 9 | A |
| 2.2. Follow-up on the recent pharmacotherapy updates | 10, 13, 9 | A |
| 2.3. Recognizes the sources of information about drug preference and councelling in special patient population such as geriatrics, pediatrics, pregnant and lactating patients | 10, 13, 38, 6, 9 | A |
| 3. Expalines patient-centered optimal treatment choices | 13, 16, 6, 9 | A |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 38: Care Plan, 4: Inquiry-Based Learning, 6: Experiential Learning, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam, E: Homework |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to Clinical Pharmacy, Patient Oriented Pharmacy, Current Status in World | 1, 2, 3, 4 |
| 2 | Therapeutic drug monitoring and laboratory tests evaluation | 1, 2, 3, 4 |
| 3 | Asthma and COPD Management | 1, 2, 3, 4, 5 |
| 4 | Upper and Lower Respiratory System Infections | 1, 2, 3, 4 |
| 5 | Peptic Ulcer and GERD | 1, 2, 3, 4 |
| 6 | Diarrhea and Constipation | 1, 2, 3, 4 |
| 7 | NSAID, Pain and fever management | 1, 2, 3, 4 |
| 8 | Diabetes | 1, 2, 3, 4, 5 |
| 9 | Hypertension | 1, 2, 3, 4, 5 |
| 10 | Kidney disease | 1, 2, 3, 4, 5 |
| 11 | Hyperlipidemia | 1, 2, 3, 4, 5 |
| 12 | Coronary artery disease | 1, 2, 3, 4, 5 |
| 13 | Heart failure | 1, 2, 3, 4, 5 |
| 14 | Venous thromboembolism | 1, 2, 3, 4, 5 |
| Resources |
| 1. Lecture Notes Reference Books: 2. Dipiro JT (2020), Pharmacotherapy A Pathophysiologic Approach (11th ed.) McGraw Hill, US. 3. Wiffen P (2012) Oxford Handbook of Clinical Pharmacy (2nd ed) Oxford Uni P 4. Whittleseas C (2019), Clinical Pharmacy and Therapeutics (6th ed) Elsevier |
| 5. Updated treatment guidelines |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | ||||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | ||||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | ||||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | ||||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |